JPWO2021067571A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021067571A5 JPWO2021067571A5 JP2022520386A JP2022520386A JPWO2021067571A5 JP WO2021067571 A5 JPWO2021067571 A5 JP WO2021067571A5 JP 2022520386 A JP2022520386 A JP 2022520386A JP 2022520386 A JP2022520386 A JP 2022520386A JP WO2021067571 A5 JPWO2021067571 A5 JP WO2021067571A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- solid particles
- seq
- subject
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962910998P | 2019-10-04 | 2019-10-04 | |
| US62/910,998 | 2019-10-04 | ||
| PCT/US2020/053758 WO2021067571A1 (en) | 2019-10-04 | 2020-10-01 | Targeted pulmonary delivery compositions and methods using same |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022550452A JP2022550452A (ja) | 2022-12-01 |
| JP2022550452A5 JP2022550452A5 (https=) | 2023-10-05 |
| JPWO2021067571A5 true JPWO2021067571A5 (https=) | 2023-10-05 |
| JP7692218B2 JP7692218B2 (ja) | 2025-06-13 |
Family
ID=75337530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520386A Active JP7692218B2 (ja) | 2019-10-04 | 2020-10-01 | ターゲティングされた肺送達組成物およびそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220332759A1 (https=) |
| EP (1) | EP4041276A4 (https=) |
| JP (1) | JP7692218B2 (https=) |
| AU (1) | AU2020357866A1 (https=) |
| CA (1) | CA3153476A1 (https=) |
| WO (1) | WO2021067571A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230241203A1 (en) * | 2020-07-06 | 2023-08-03 | Rutgers, The State University Of New Jersey | Enhancing immune responses through targeted antigen expression |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7041814B1 (en) * | 1998-02-18 | 2006-05-09 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics |
| US20050036951A1 (en) * | 2003-01-09 | 2005-02-17 | Arizeke Pharmaceuticals, Inc. | Methods of treating lung diseases |
| US7659252B2 (en) * | 2005-09-15 | 2010-02-09 | Novomed Technologies, Inc. (Shanghai) | Transdermal delivery peptides and method of use thereof |
-
2020
- 2020-10-01 WO PCT/US2020/053758 patent/WO2021067571A1/en not_active Ceased
- 2020-10-01 CA CA3153476A patent/CA3153476A1/en active Pending
- 2020-10-01 AU AU2020357866A patent/AU2020357866A1/en active Pending
- 2020-10-01 US US17/765,379 patent/US20220332759A1/en active Pending
- 2020-10-01 JP JP2022520386A patent/JP7692218B2/ja active Active
- 2020-10-01 EP EP20871920.3A patent/EP4041276A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Das et al. | Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review | |
| CN111971066B (zh) | 脂质纳米颗粒 | |
| JP2025063030A5 (https=) | ||
| JP4535211B2 (ja) | コクリエート送達ビヒクル | |
| EP1355628A2 (en) | Stabilised polymeric aerosols for pulmonary gene delivery | |
| JP2016533332A (ja) | 自己集合型ナノ粒子ワクチン | |
| CN115624524B (zh) | Peg化白蛋白修饰的溶瘤病毒静脉递送制剂的制备及其应用 | |
| TWI883381B (zh) | ｍＲＮＡ分子、ＤＮＡ分子、重組質體、脂質奈米顆粒、藥物組合物、新型冠狀病毒ｍＲＮＡ疫苗及其製備方法與用途 | |
| JP2023536570A (ja) | 抗原のターゲティング発現による免疫応答の増強法 | |
| JP2024530047A (ja) | ワクチン抗原 | |
| BRPI0811692A2 (pt) | material com imunogenicidade | |
| JPWO2021067571A5 (https=) | ||
| JP2023536269A (ja) | ワクチン組成物及びその使用方法 | |
| US20030008000A1 (en) | DNA vaccine using liposome-encapsulated plasmid DNA encoding for hemagglutinin protein of influenza virus | |
| TW202120123A (zh) | 類屈公病毒顆粒疫苗及使用其之方法 | |
| US20250101066A1 (en) | Viral Vaccines | |
| CN118562832A (zh) | 编码HTNV包膜糖蛋白GP的基因、其编码的表达载体、mRNA分子及其用途 | |
| JP2006515354A (ja) | 医薬エアロゾル組成物 | |
| CN110382518B (zh) | 用于血清型a型口蹄疫病毒的嵌合疫苗 | |
| CN117838849A (zh) | 一种多价腺病毒载体重组新型冠状病毒吸入疫苗及其制备方法和应用 | |
| JP2025529906A (ja) | コロナウイルスに対するワクチン | |
| CN120390752A (zh) | 靶向具有半胱天冬酶激活和募集结构域(asc)的凋亡相关斑点样蛋白的组合物及使用方法 | |
| CN118647399A (zh) | 病毒样颗粒和微晶酪氨酸的组合物 | |
| WO2024257026A1 (en) | Virus-like particles for the treatment of sars-cov2 | |
| KR20260057400A (ko) | Sars-cov2 치료용 바이러스-유사 입자 |